|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fleshman JW and Smallwood N: Current
concepts in rectal cancer. Clin Colon Rectal Surg. 28:5–11. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rao AKDM, Rajkumar T and Mani S:
Perspectives of long non-coding RNAs in cancer. Mol Biol Rep.
44:203–218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li M, Wang Y, Cheng L, Niu W, Zhao G, Raju
JK, Huo J, Wu B, Yin B, Song Y and Bu R: Long non-coding RNAs in
renal cell carcinoma: A systematic review and clinical
implications. Oncotarget. 8:48424–48435. 2017.PubMed/NCBI
|
|
6
|
Klingenberg M, Matsuda A, Diederichs S and
Patel T: Non-coding RNA in hepatocellular carcinoma: Mechanisms,
biomarkers and therapeutic targets. J Hepatol. 67:603–618. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Richtig G, Ehall B, Richtig E,
Aigelsreiter A, Gutschner T and Pichler M: Function and clinical
implications of long non-coding RNAs in melanoma. Int J Mol Sci.
18:pii: E715. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Y, Zhao L, Lei L, Lau WB, Lau B, Yang
Q, Le X, Yang H, Wang C, Luo Z, et al: LncRNAs: The bridge linking
RNA and colorectal cancer. Oncotarget. 8:12517–12532.
2017.PubMed/NCBI
|
|
9
|
Wang Y, He L, Du Y, Zhu P, Huang G, Luo J,
Yan X, Ye B, Li C, Xia P, et al: The long noncoding RNA lncTCF7
promotes self-renewal of human liver cancer stem cells through
activation of Wnt signaling. Cell Stem Cell. 16:413–425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weber BN, Chi AW, Chavez A, Yashiro-Ohtani
Y, Yang Q, Shestova O and Bhandoola A: A critical role for TCF-1 in
T-lineage specification and differentiation. Nature. 476:63–68.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui L, Guan Y, Qu Z, Zhang J, Liao B, Ma
B, Qian J, Li D, Li W, Xu GT and Jin Y: WNT signaling determines
tumorigenicity and function of ESC-derived retinal progenitors. J
Clin Invest. 123:1647–1661. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nikuseva-Martic T, Serman L, Zeljko M,
Vidas Z, Gašparov S, Zeljko HM, Kosović M and Pećina-Šlaus N:
Expression of secreted frizzled-related protein 1 and 3, T-cell
factor 1 and lymphoid enhancer factor 1 in clear cell renal cell
carcinoma. Pathol Oncol Res. 19:545–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siu MK, Chen WY, Tsai HY, Chen HY, Yin JJ,
Chen CL, Tsai YC and Liu YN: TCF7 is suppressed by the androgen
receptor via microRNA-1-mediated downregulation and is involved in
the development of resistance to androgen deprivation in prostate
cancer. Prostate Cancer Prostatic Dis. 20:172–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen WY, Liu SY, Chang YS, Yin JJ, Yeh HL,
Mouhieddine TH, Hadadeh O, Abou-Kheir W and Liu YN: MicroRNA-34a
regulates WNT/TCF7 signaling and inhibits bone metastasis in
Ras-activated prostate cancer. Oncotarget. 6:441–457.
2015.PubMed/NCBI
|
|
15
|
Wang Y, Zhang S, Xu Y, Zhang Y, Guan H, Li
X, Li Y and Wang Y: Upregulation of miR-192 inhibits cell growth
and invasion and induces cell apoptosis by targeting TCF7 in human
osteosarcoma. Tumour Biol. 37:15211–15220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J and Wang D: Long noncoding RNA TCF7
promotes invasiveness and self-renewal of human non-small cell lung
cancer cells. Hum Cell. 30:23–29. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu J, Zhang J, Shen B, Yin K, Xu J, Gao W
and Zhang L: Long noncoding RNA lncTCF7, induced by IL-6/STAT3
transactivation, promotes hepatocellular carcinoma aggressiveness
through epithelial-mesenchymal transition. J Exp Clin Cancer Res.
34:1162015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li C, Liang G, Yang S, Sui J, Yao W, Shen
X, Zhang Y, Peng H, Hong W, Xu S, et al: Dysregulated lncRNA-UCA1
contributes to the progression of gastric cancer through regulation
of the PI3K-Akt-mTOR signaling pathway. Oncotarget. 8:93476–93491.
2017.PubMed/NCBI
|
|
20
|
Xu C, Sun L, Jiang C, Zhou H, Gu L, Liu Y
and Xu Q: SPP1, analyzed by bioinformatics methods, promotes the
metastasis in colorectal cancer by activating EMT pathway. Biomed
Pharmacother. 91:1167–1177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan Y, Jiao G, Wang C, Yang J and Yang W:
MicroRNA-421 inhibits breast cancer metastasis by targeting
metastasis associated 1. Biomed Pharmacother. 83:1398–1406. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Romagnoli P, Filipponi F, Bandettini L and
Brugnola D: Increase of mitotic activity in the colonic mucosa of
patients with colorectal cancer. Dis Colon Rectum. 27:305–308.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paganelli GM, Biasco G, Santucci R, Brandi
G, Lalli AA, Miglioli M and Barbara L: Rectal cell proliferation
and colorectal cancer risk level in patients with nonfamilial
adenomatous polyps of the large bowel. Cancer. 68:2451–2454. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao M, Lam EC, Kelly CR, Zhou W and Wolfe
MM: Cyclooxygenase-2 selective inhibition with NS-398 suppresses
proliferation and invasiveness and delays liver metastasis in
colorectal cancer. Br J Cancer. 90:712–719. 2004. View Article : Google Scholar : PubMed/NCBI
|
